Thyrocare Technologies declares 70% interim dividend; record date fixed

Thyrocare Technologies has announced an interim dividend of Rs 7 per equity share, representing 70 per cent of the face value of Rs 10 each. The company has fixed October 24, 2025 as the record date to determine shareholders eligible for the payout.

The dividend announcement comes as the diagnostics major celebrates its 25th anniversary and marks the festive season of Diwali. The board’s decision reflects Thyrocare’s strong financial health, backed by steady revenue growth, improved profitability and a strong cash position.

During the first half of FY26, the company reported healthy operational performance, aided by network expansion and rising test volumes. Thyrocare remains debt-free and holds net cash and equivalents of over Rs 190 crore.

Rahul Guha, Managing Director and CEO of Thyrocare Technologies, said the dividend highlights the company’s focus on creating long-term value for shareholders. “Our financial performance and network expansion underscore Thyrocare’s commitment to delivering high-quality, affordable diagnostic services while rewarding shareholders for their continued trust,” he said.

The interim dividend follows a strong second quarter performance, where the company posted an 82 per cent year-on-year rise in profit after tax and a 22 per cent increase in revenue. The growth was supported by a 21 per cent jump in test volumes and strong momentum in its pathology segment.

Thyrocare, one of India’s leading diagnostic service providers, continues to expand its footprint in underserved regions, recently adding laboratories in Vijayawada, Bhagalpur, Roorkee and Kashmir.

The dividend will be paid to eligible shareholders after the record date as per the company’s standard payout timeline.

End of article